Skip to main content
. 2020 Oct 20;2(3):100110. doi: 10.1016/j.jtocrr.2020.100110

Table 2.

Sample Characteristics and Covariates

Descriptor Overall (n = 75)
Median interval between scan and blood collection, d (range) 1 (0–16)
Bone metastases at time of scan, n (%)
 Present 24 (32)
 Absent 51 (68)
Treatment-naive or pretreatment sample,a n (%)
 Yes 13 (17)
 No 62 (83)
Treatment status at time of blood collection, n (%)
 On treatment 27 (36)
 Chemotherapy alone 12 (16)
 Chemotherapy with concurrent radiation 2 (3)
 Immunotherapy 9 (12)
 Other 4 (5)
Off treatment 48 (64)
a

In the treatment-naive and pretreatment analyses, n = 11 as two samples were excluded to ensure one sample per patient.